-
Jul 30, 2024 | 
jamanetwork.com | william wang |Nora D. Volkow |Nathan A Berger |Pamela Davis
Introduction Drug overdose fatalities in the United States remain high, with an estimated 107 543 deaths in 2023, mostly from opioids.1 Despite the effectiveness of medications for opioid use disorder (OUD) in preventing overdoses, only an estimated 25% of individuals with OUD receive them,2 and close to 50% discontinue treatment within 6 months. There is an urgency for alternative treatments for OUD.
-
Jun 18, 2024 | 
nature.com | Nora D. Volkow |Nathan A Berger |Pamela Davis |David C. Kaelber
Correction to: Nature Communications https://doi.org/10.1038/s41467-024-48780-6, published online 28 May 2024In this article in the abstract the word clinical was misspelt as clinicl.
-
May 27, 2024 | 
nature.com | Nora D. Volkow |Nathan A Berger |Pamela Davis |David C. Kaelber
AbstractAlcohol use disorders are among the top causes of the global burden of disease, yet therapeutic interventions are limited. Reduced desire to drink in patients treated with semaglutide has raised interest regarding its potential therapeutic benefits for alcohol use disorders.
-
Jan 5, 2024 | 
nature.com | Nora D. Volkow |Nathan A Berger |Pamela Davis |David C. Kaelber
AbstractConcerns over reports of suicidal ideation associated with semaglutide treatment, a glucagon-like peptide 1 receptor (GLP1R) agonist medication for type 2 diabetes (T2DM) and obesity, has led to investigations by European regulatory agencies. In this retrospective cohort study of electronic health records from the TriNetX Analytics Network, we aimed to assess the associations of semaglutide with suicidal ideation compared to non-GLP1R agonist anti-obesity or anti-diabetes medications.
-
Dec 27, 2023 | 
youhavetoliveyour.life | Hayley Gleeson |Lindsey Wang |Pamela Davis |Nathan A Berger
Australian Broadcasting Corporation Other / Mixed Journalist Study Other / Mixed Article on a study Journalist Article on a study Journalist Other / Mixed Group of professionals Study Other / Mixed Johns Hopkins Bloomberg School of Public Health Other / Mixed Other / Mixed University of Auckland News and Opinion Article on a study Other / Professional Article on a study Other / Mixed...
-
Nov 22, 2023 | 
nature.com | Pamela Davis |David C. Kaelber
AbstractThe Centers for Disease Control and Prevention announced in January 2023 a potential connection between administration of the Pfizer novel coronavirus disease-2019 (COVID-19) bivalent vaccine booster and ischemic stroke (IS). A retrospective cohort study was conducted to compare the hazard of IS in patients aged 65 years and over administered the Pfizer bivalent booster versus those administered the Pfizer/Moderna monovalent or Moderna bivalent boosters.
-
Oct 1, 2023 | 
fmch.bmj.com | Lindsey Wang |Pamela Davis |Nathan E. Berger |David C. Kaelber
Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0–5 years in the USA in 2022: a multicentre retrospective cohort study Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Aug 16, 2023 | 
onlinelibrary.wiley.com | Lindsey Wang |Nora D. Volkow |Nathan A Berger |Pamela Davis
1 INTRODUCTION More than 109,000 Americans died of drug overdose in 2022, with 81,231 overdose deaths involving opioids (The Centers for Disease Control and Prevention—Vital Statistics Rapid Release - Provisional Drug Overdose Data, 2023). Methadone, buprenorphine and naltrexone are the most widely used medications for opioid use disorders (MOUD) and the most effective intervention for preventing overdose deaths (Volkow, 2021; Volkow & Blanco, 2021; Volkow et al., 2014).
-
May 16, 2023 | 
medrxiv.org | Lindsey Wang |Pamela Davis |Nathan A Berger |David C. Kaelber
AbstractRespiratory syncytial virus (RSV) infections and hospitalizations surged sharply in 2022 among young children. To assess whether COVID-19 contributed to this surge, we leveraged a real-time nation-wide US database of electronic health records (EHRs) using time series analysis from January 1, 2010 through January 31, 2023, and propensity-score matched cohort comparisons for children aged 0–5 years with or without prior COVID-19 infection.
-
Feb 14, 2023 | 
medrxiv.org | Pamela Davis |David C. Kaelber |Rong Xu |Maria P. Gorenflo
AbstractImportance The Centers for Disease Control and Prevention (CDC) announced in January 2023 that they were investigating a potential connection between administration of the Pfizer novel coronavirus disease-2019 (COVID-19) bivalent vaccine booster and ischemic stroke (IS). Objective To explore the relationship between Pfizer bivalent booster administration and IS in older patients in the United States and compare it to other COVID-19 vaccines.
